Abstract:OBJECTIVE: To examine the characteristics of the evidence-based clinical literatures regarding the Chinese patent medicines on the National Essential Medicine List of China (2009 Edition) so as to lay a foundation for the establishment of an evidence-based pharmaceutical review system for the Chinese patent medicines oriented at treating TCM-syndromes. METHODS: The evidence-based literatures on Chinese patent medicines were categorized, and their characteristics were analyzed concerning the distribution of the literatures according to the five levels of evidence, the concentration of the diseases under treatment, and chronological changes; in accordance with the Drug Registration Regulation, the differences among these literatures were explored. RESULTS: With regard to the literatures on some Chinese patent medicines, there were a large proportion of randomized controlled trials (RCTs), with a rapid increase in the number of the literatures in recent years and a clear focus on certain diseases. By contrast, some other Chinese patent medicines had a high proportion of before-after studies and empirical introductions as well as a low concentration of diseases under treatment. CONCLUSION: The Chinese patent medicines can be divided into two categories, namely, the modern branch and the traditional branch. While the disease-oriented evidence-based review system can be applied to the evaluation of the literatures on some patent medicines in the modern branch, it does not fit the traditional branch. Therefore, in order to reflect the characteristics of the Chinese patent medicines, a TCM-syndrome-oriented evidence-based review system has to be established. Copyright 2012 by the Chinese Pharmaceutical Association.

Discussing on the function and indication of Traditional Chinese patent Medicine from ChP published in 2005

A Review and Expectation of the Specification of Major Function Indicated of Chinese Patent Medicine in the Chinese Pharmacopoeia

Analysis on DING Xueping's Herbal Administration Experience for Diabetic Peripheral Neuropathy by Using Traditional Chinese Medicine Inheritance Support System

Notice for Western Medicine Physicians in Clinical Use of Chinese Patent Drugs

Recent advances in Chinese patent medicines entering the international market

[Summary and analysis of safety warning on clinical application of anti-cold Chinese patent medicine preparations]

Progress of Modernization in Chinese Traditional Medicine and Patent Medicine

Research into Evidence-based Literatures on the Chinese Patent Medicines on the National Essential Medicine List

[Guideline for clinical comprehensive evaluation of Chinese patent medicine (2022 version)]

[Discussion on issues related to clinical experts consensus of Chinese patent medicine]

Analysis of Medicine-related Issues in New "patent Law"

Some Issues about Meridian Distribution of Traditional Chinese Medicine in Chinese Pharmacopoeia(2005)

Research on the Protection Strategy of the Traditional Chinese Medicine Intellectual Property

Analysis of Outpatient Chinese Traditional Patent Medicine Prescriptions During the Third Quarter of 2008 in Our Hospital

The exploration on criteria and compromise in the prescription review of Chinese patent medicines X: medication for children

Property theory of Chinese materia medica: Clinical pharmacodynamics of traditional Chinese medicine

Analysis of Medicinal Substances and Cut Crude Drugs with Forbidding,Contraindication or Caution for Pregnancy in Chinese Pharmacopoeia(2005)

Research on the Path to Breakthrough in the Dilemma of Chinese Traditional Medicine Intellectual Property Protection

Analysis of 136 ADRs Induced by Chinese Patent Medicine

Utilization of Chinese Patent Medicines in Our Hospital

Perspective on Chinese Drugs Dispensing